About Zanubrutinib API
Therapeutic CategoryAnti-Cancer/ Oncology
CAS Number
1691249-45-2
API Technology
Synthetic
Dose Form
Oral Solid/Capsules
Dr Reddy's Development Status
Under Development
Mechanism of Action
Zanubrutinib is a Bruton's tyrosine kinase (BTK) inhibitor. It works by blocking BTK, a protein that signals B-cells to grow and multiply, thereby inhibiting the proliferation and survival of malignant B cells
Indication
Zanubrutinib is indicated for the treatment of:
Chronic lymphocytic leukemia (CLL)
Small lymphocytic lymphoma (SLL)
Waldenström's macroglobulinemia (WM)
Mantle cell lymphoma (MCL)
Marginal zone lymphoma (MZL)
Relapsed or refractory follicular lymphoma (FL)
Related APIs
Abiraterone Acetate
Anti-Cancer/ Oncology
Adagrasib
Anti-Cancer/ Oncology
Apalutamide (Amorphous & Form B)
Anti-Cancer/ Oncology
Azacitidine
Anti-Cancer/ Oncology
Bendamustine Hydrochloride
Anti-Cancer/ Oncology
Bortezomib
Anti-Cancer/ Oncology
Cabazitaxel
Anti-Cancer/ Oncology
Cabozantinib HCl
Anti-Cancer/ Oncology
Cabozantinib S-Malate
Anti-Cancer/ Oncology
Capecitabine
Anti-Cancer/ Oncology
Carfilzomib
Anti-Cancer/ Oncology
Darolutamide
Anti-Cancer/ Oncology
Dasatinib (Monohydrate)
Anti-Cancer/ Oncology
Decitabine
Anti-Cancer/ Oncology
Deucravacitinib
Anti-Cancer/ Oncology
Enzalutamide
Anti-Cancer/ Oncology
Eribulin (Available For Selected Markets)
Anti-Cancer/ Oncology
Fosaprepitant
Anti-Cancer/ Oncology
Fruquintinib
Anti-Cancer/ Oncology
Gemcitabine Hydrochloride
Anti-Cancer/ Oncology
Granisteron
Anti-Cancer/ Oncology
Lenalidomide (Form A)
Anti-Cancer/ Oncology
Lenvatinib Mesylate ( MIBK Solvate)
Anti-Cancer/ Oncology
Lenvatinib Mesylate (Form-C)
Anti-Cancer/ Oncology
Lomustine
Anti-Cancer/ Oncology
Midostaurin
Anti-Cancer/ Oncology
Nilotinib Hydrochloride Monohydrate (Form B)
Anti-Cancer/ Oncology
Niraparib Tosylate
Anti-Cancer/ Oncology
Olaparib (Form A)
Anti-Cancer/ Oncology
Palbociclib
Anti-Cancer/ Oncology
Pazopanib
Anti-Cancer/ Oncology
Pemetrexed Disodium Heptahydrate
Anti-Cancer/ Oncology
Pirtobrutinib
Anti-Cancer/ Oncology
Pomalidomide
Anti-Cancer/ Oncology
Relugolix
Anti-Cancer/ Oncology
Ripretinib
Anti-Cancer/ Oncology
Ritlecitinib
Anti-Cancer/ Oncology
Ruxolitinib Phosphate
Anti-Cancer/ Oncology
Tucatinib
Anti-Cancer/ Oncology
Venetoclax
Anti-Cancer/ Oncology
Zanubrutinib
Anti-Cancer/ Oncology
Zoledronic Acid
Anti-Cancer/ Oncology
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!